Charles River Laboratories International Inc. (NYSE: CRL) is -22.70% lower on its value in year-to-date trading and has touched a low of $161.65 and a high of $275.00 in the current 52-week trading range. The question becomes, what are the chances the stock will make a comeback and enjoy potential growth. Why not look at analysts view on what the future holds for the stock. The CRL stock was last observed hovering at around $186.63 in the last trading session, with the day’s loss setting it -3.9%.
Currently trading at $182.73, the stock is -4.80% and -6.93% below its SMA20 and SMA50 respectively. However, with a daily trading volume of 1.05 million and changing -2.09% at the moment leaves the stock -17.39% off its SMA200. CRL registered -0.50% loss for a year compared to 6-month loss of -19.79%. The firm has a 50-day simple moving average (SMA 50) of $196.3354 and a 200-day simple moving average (SMA200) of $221.1928.
The stock witnessed a -5.27% gain in the last 1 month and extending the period to 3 months gives it a -21.73%, and is -7.61% down over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 3.00% over the week and 2.58% over the month.
Charles River Laboratories International Inc. (CRL) has around 21800 employees, a market worth around $9.43B and $4.08B in sales. Current P/E ratio is 21.60 and Fwd P/E is 17.48. Profit margin for the company is 10.73%. Distance from 52-week low is 13.04% and -33.55% from its 52-week high. The company has generated returns on investments over the last 12 months (6.67%).
The EPS is expected to shrink by -6.23% this year
929.0 institutions hold shares in Charles River Laboratories International Inc. (CRL), with institutional investors hold 104.56% of the company’s shares. The shares outstanding are 51.34M, and float is at 51.06M with Short Float at 3.86%. Institutions hold 103.58% of the Float.
The top institutional shareholder in the company is VANGUARD GROUP INC with over 6.1 million shares valued at $1.26 billion. The investor’s holdings represent 11.8396 of the CRL Shares outstanding. As of 2024-06-30, the second largest holder is BLACKROCK INC. with 5.09 million shares valued at $1.05 billion to account for 9.8699 of the shares outstanding. The other top investors are STATE STREET CORP which holds 2.09 million shares representing 4.052 and valued at over $431.52 million, while KAYNE ANDERSON RUDNICK INVESTMENT MANAGEMENT LLC holds 3.7031 of the shares totaling 1.91 million with a market value of $394.36 million.
Charles River Laboratories International Inc. (CRL) Insider Activity
The most recent transaction is an insider sale by LaPlume Joseph W, the company’s EVP, Corp Strategy & Develop. SEC filings show that LaPlume Joseph W sold 1,780 shares of the company’s common stock on Aug 08 ’24 at a price of $199.36 per share for a total of $0.35 million. Following the sale, the insider now owns 22521.0 shares.
Still, SEC filings show that on Aug 01 ’24, FOSTER JAMES C (Chairman, President and CEO) disposed off 25,000 shares at an average price of $250.00 for $6.25 million. The insider now directly holds 188,251 shares of Charles River Laboratories International Inc. (CRL).
